UNSPSC 85819419: Transfusion of nonautologous antihemophilic factors into peripheral vein, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous antihemophilic factors into peripheral vein, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30230V1

UNSPSC 85819419 Transfusion of nonautologous antihemophilic factors into peripheral vein, open approach is a Commodity code whose stated scope does not align with the recent state and local contract opportunities posted under it. The six opportunities in the recent record span independent medical evaluation services for pension disability determinations, surgical procedure carve-out benefits for municipal employees, occupational medical surveillance for ferry workers, specialty and emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve antihemophilic factor transfusions or related blood product administration. The mismatch suggests this code receives infrequent or misclassified tagging in state and local procurement systems.

The issuing bodies in the recent record include a municipal retirement office (City of Phoenix), two municipalities (City of Long Beach, Washington State Department of Transportation), a county health system (County of Santa Clara), a county juvenile probation department (Harris County), and a county commissioners board (Collier County). Activity appears across Arizona, California, Florida, and Washington, with no geographic concentration evident. Given the absence of opportunities actually requesting antihemophilic factor procurement or related hematology services under this code, pursuit would require either confirmation that issuing bodies are using the code incorrectly or direct outreach to identify whether state and local health systems, corrections departments, or other public agencies are procuring clotting factor products through alternative code pathways or informal vendor relationships rather than formal solicitation.